NutriStack
Inositol and Metformin, a synergy.
Myo-inositol and D-chiro-inositol act as second messengers downstream of the insulin receptor and improve insulin sensitivity, fasting glucose, and HOMA-IR in PCOS and type 2 diabetes. Network meta-analyses suggest myo-inositol combined with metformin outperforms metformin alone for several metabolic endpoints in PCOS. The combination is generally beneficial, with low hypoglycemia risk because metformin and inositol both act as insulin sensitizers rather than insulin secretagogues.
One pair, every claim cited. The two substances, the type, the mechanism, the recommendation, and the primary literature.
Same shape as the other 1,729 pairs in the public database.
From the interaction database
What the row says.
Every entry follows the same shape: what is happening, the mechanism, the recommendation, and the primary literature.
At a glance
- Pair type
- Synergy
- Evidence (highest tier)
- Moderate
- Source citations
- 2 sources
- Stack Score effect
- +2 to your Stack Score (per scored synergy row).
- Scope
- Supplement × Prescription
- Last verified
- May 30, 2026
Synergy · Moderate evidence
Synergy
What is happening. Myo-inositol and D-chiro-inositol act as second messengers downstream of the insulin receptor and improve insulin sensitivity, fasting glucose, and HOMA-IR in PCOS and type 2 diabetes. Network meta-analyses suggest myo-inositol combined with metformin outperforms metformin alone for several metabolic endpoints in PCOS. The combination is generally beneficial, with low hypoglycemia risk because metformin and inositol both act as insulin sensitizers rather than insulin secretagogues.
Mechanism. Myo-inositol and D-chiro-inositol generate inositol phosphoglycan second messengers that improve insulin signaling and GLUT4-mediated glucose uptake. Metformin activates AMPK, inhibits hepatic gluconeogenesis, and reduces mitochondrial complex I activity. The mechanisms converge on improved insulin sensitivity without driving insulin secretion.
Recommendation. If you take metformin for PCOS or insulin resistance, adding myo-inositol (commonly 2-4 g daily) is generally safe and may improve glycemic and reproductive outcomes. Continue routine glucose monitoring; severe hypoglycemia is unlikely unless you also take insulin or a sulfonylurea.
Sources (2)
- Zhao H, Xing C, Zhang J, He B. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis. Reprod Health. 2021;18(1):171. PMID 34407851
- Greff D, Juhász AE, Váncsa S, et al. Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2023;21(1):10. PMID 36703143
Stack Score
How this pair moves the number.
Effect on the composite score
If both Inositol and Metformin are in the same stack, this pair applies +2 to your Stack Score (per scored synergy row).
The full algorithm, the clamping rules, and four worked stacks are documented at /methodology/stack-score.
Check your full routine
One pair was the worked example. NutriStack runs every pair in your stack at once.
Drop in your supplements and prescriptions and the public database surfaces every interaction, synergy, timing rule, and contraindication, every one linked to its primary source.